Uniondale, NY6 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Uniondale, NY

Find 6 actively recruiting myalgic encephalomyelitis clinical trials in Uniondale, NY. Connect with local research sites and explore new treatment options.

6
Active Trials
1
Sponsors
731
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Uniondale

About Myalgic Encephalomyelitis Clinical Trials in Uniondale

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 6 myalgic encephalomyelitis clinical trials recruiting participants in Uniondale, NY. These studies are seeking a combined 731 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Uniondale — FAQ

Are there myalgic encephalomyelitis clinical trials in Uniondale?

Yes, there are 6 myalgic encephalomyelitis clinical trials currently recruiting in Uniondale, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Uniondale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Uniondale research site will contact you about next steps.

Are clinical trials in Uniondale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Uniondale studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 6 active trials in Uniondale are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov